Nationales Centrum für Tumorerkrankungen Dresden
- Research works
- 117 ▲ 507% vs 2013–17
- Citations
- 2.5k 21.9 per fractional work
- Top-10% rate
- 27.4% record average 16.5%
- Open access
- 73% world 28%
Not ranked overall: Nationales Centrum für Tumorerkrankungen Dresden is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.
- Immunology and Microbiology 4.4×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Neuroscience 0.7×
- Computer Science 0.6×
- Physics and Astronomy 0.5×
- Health Professions 0.4×
- Chemistry 0.3×
- Engineering 0.3×
- Decision Sciences 0.3×
- Mathematics 0.2×
- Economics, Econometrics and Finance 0.2×
- Nursing 0.2×
- Materials Science 0.2×
- Chemical Engineering 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.0×
- Psychology 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at Nationales Centrum für Tumorerkrankungen Dresden?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Tumor Microenvironment, Prognostic Factors, Neoadjuvant Therapy, Clinical Practice Guidelines, Cancer Immunotherapy and Targeted Therapy.
- Virtual Reality Training
- Sentinel Lymph Node Biopsy
- Adjuvant Chemotherapy
- Molecular Classification
- Genomic Instability
- Medical Education
- Metastasis
- Chimeric Antigen Receptor
- Tumor Regression
- Lymphoma
- Immunity
- PD-1 and PD-L1
- Precision Medicine
- Radiotherapy
- Clinical Trials
- Targeted Therapy
- Cancer Immunotherapy
- Clinical Practice Guidelines
- Cancer
- Chemotherapy
- Immunotherapy
- Tumor Microenvironment
- Prognostic Factors
- Neoadjuvant Therapy
- Cancer Therapy
- Survival Analysis
- Genetic Mutations
- Laparoscopic Surgery
- Immune Checkpoint Blockade
- Biomarkers
- Robotic Surgery
- Medical Imaging
- CAR T Cells
- Melanoma
- PET Imaging
- Dosimetry
- Hematopoietic Stem Cells
- Innate Immunity
- Pancreatic Cancer
- Surgical Skills
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy7▲ 16×15 topics
- Chemotherapy5▲ 12×17 topics
- Tumor Microenvironment4▲ 17×7 topics
- Cancer3▲ 4.2×31 topics
- Prognostic Factors3▲ 11×12 topics
- Clinical Practice Guidelines3▲ 8.4×9 topics
- Neoadjuvant Therapy3▲ 20×5 topics
- Cancer Immunotherapy2▲ 28×3 topics
- Cancer Therapy2▲ 7.6×11 topics
- Targeted Therapy2▲ 19×5 topics
- Survival Analysis2▲ 15×6 topics
- Clinical Trials2▲ 5.5×6 topics
- Genetic Mutations2▲ 8.2×11 topics
- Radiotherapy2▲ 9.4×7 topics
- Laparoscopic Surgery2▲ 28×2 topics
- Precision Medicine2▲ 6.9×6 topics
- Immune Checkpoint Blockade2▲ 28×1 topic
- PD-1 and PD-L12▲ 28×1 topic
- Biomarkers2▲ 4.2×7 topics
- Immunity2▲ 7.1×7 topics
- Robotic Surgery2▲ 20×3 topics
- Lymphoma2▲ 17×2 topics
- Medical Imaging2▲ 5.3×4 topics
- Tumor Regression2▲ 26×2 topics
- CAR T Cells2▲ 34×1 topic
- Chimeric Antigen Receptor2▲ 34×1 topic
- Melanoma2▲ 44×2 topics
- Metastasis2▲ 7.5×12 topics
- PET Imaging2▲ 15×4 topics
- Medical Education1▲ 9.6×4 topics
- Dosimetry1▲ 32×2 topics
- Genomic Instability1▲ 20×3 topics
- Hematopoietic Stem Cells1▲ 25×2 topics
- Molecular Classification1▲ 14×3 topics
- Innate Immunity1▲ 6.7×8 topics
- Adjuvant Chemotherapy1▲ 28×2 topics
- Pancreatic Cancer1▲ 18×2 topics
- Sentinel Lymph Node Biopsy1▲ 23×2 topics
- Surgical Skills1▲ 49×1 topic
- Virtual Reality Training1▲ 49×1 topic
Which research topics does Nationales Centrum für Tumorerkrankungen Dresden publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Surgical Simulation and Training and Pancreatic and Hepatic Oncology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 CAR-T cell therapy research Oncology 2 works
- 3 Surgical Simulation and Training Surgery 1 works
- 4 Pancreatic and Hepatic Oncology Research Oncology 1 works
- 5 Immunotherapy and Immune Responses Immunology 1 works
- 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
- 7 Cancer survivorship and care Oncology 1 works
- 8 Cancer Genomics and Diagnostics Cancer Research 1 works
- 9 Acute Myeloid Leukemia Research Hematology 1 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Nationales Centrum für Tumorerkrankungen Dresden's research output changed?
Output in 2018–2022 was 507% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dresden
- Technische Universität Dresden
- Helmholtz-Zentrum Dresden-Rossendorf
- University Hospital Carl Gustav Carus
- Leibniz Institute for Solid State and Materials Research
- Klinik und Poliklinik für Urologie
- Max Planck Institute for the Physics of Complex Systems
- Leibniz Institute of Polymer Research
- Klinik und Poliklinik für Psychotherapie und Psychosomatik
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.